Impacting lives at the research park…. the pig, provided by Revivicor, which raises pigs for transplant, was genetically modified in 10 different spots before birth. “We’ve marched down this road over the last decade, going from a one-gene pig to a two- to a five- to an eight to a 10, and we rationalized each of those and made modifications along the way,” Ayares said.
Revivicor’s parent company, United Therapeutics, aims to get into pig-to-human lung transplants, whose pigs will probably need “at least that many” gene edits, Ayares said.
Read full story by Karen Weintraub USA TODAY